U.S.-based Sites Earn Gold for Second Consecutive Year TriMas (NASDAQ: TRS) today announced that its TriMas Packaging group has retained the Gold level rating for...
The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular features for personalized, accurate and more effective monitoring of molecular residual disease. Datar...